Company intelligence / Profile preview
Large Scale Biology
- Ownership
- Private
- Development stage
- Other
Overview
Large Scale Biology Corporation developed scalable methods for manufacturability of peptide display vaccines using tobacco mosaic virus technology; no clinical-stage results or products reached market
- Therapeutic areas
- Infectious Diseases
- Modalities
- PeptidesRecombinant proteinVaccineBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Large Scale Biology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Large Scale Biology.